enVVeno Medical Statistics
Total Valuation
NVNO has a market cap or net worth of $59.45 million. The enterprise value is $11.51 million.
Important Dates
The last earnings date was Thursday, October 31, 2024, before market open.
| Earnings Date | Oct 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NVNO has 17.54 million shares outstanding. The number of shares has increased by 68.13% in one year.
| Shares Outstanding | 17.54M |
| Shares Change (YoY) | +68.13% |
| Shares Change (QoQ) | +20.93% |
| Owned by Insiders (%) | 0.29% |
| Owned by Institutions (%) | 19.09% |
| Float | 17.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.24 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.01, with a Debt / Equity ratio of 0.02.
| Current Ratio | 22.01 |
| Quick Ratio | 21.70 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -58.76% and return on invested capital (ROIC) is -39.05%.
| Return on Equity (ROE) | -58.76% |
| Return on Assets (ROA) | -37.28% |
| Return on Capital (ROIC) | -39.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$685,129 |
| Employee Count | 31 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.72% in the last 52 weeks. The beta is 1.22, so NVNO's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | -17.72% |
| 50-Day Moving Average | 4.14 |
| 200-Day Moving Average | 4.94 |
| Relative Strength Index (RSI) | 43.22 |
| Average Volume (20 Days) | 100,762 |
Short Selling Information
The latest short interest is 549,079, so 3.13% of the outstanding shares have been sold short.
| Short Interest | 549,079 |
| Short Previous Month | 762,788 |
| Short % of Shares Out | 3.13% |
| Short % of Float | 3.14% |
| Short Ratio (days to cover) | 2.31 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -23.41M |
| Pretax Income | -20.60M |
| Net Income | -21.24M |
| EBITDA | -23.20M |
| EBIT | -23.41M |
| Earnings Per Share (EPS) | -$1.33 |
Full Income StatementBalance Sheet
The company has $48.38 million in cash and $1.15 million in debt, giving a net cash position of $47.23 million or $2.69 per share.
| Cash & Cash Equivalents | 48.38M |
| Total Debt | 1.15M |
| Net Cash | 47.23M |
| Net Cash Per Share | $2.69 |
| Equity (Book Value) | 47.37M |
| Book Value Per Share | 2.70 |
| Working Capital | 46.82M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$16.71 million and capital expenditures -$37,000, giving a free cash flow of -$16.74 million.
| Operating Cash Flow | -16.71M |
| Capital Expenditures | -37,000 |
| Free Cash Flow | -16.74M |
| FCF Per Share | -$0.95 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |